TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-59.68%
↑ 69% vs avg
Percentile
P80
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-192.86%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -59.68% | +51.4% |
| 2024 | -122.88% | +61.2% |
| 2023 | -316.86% | +16.0% |
| 2022 | -377.18% | -34.4% |
| 2021 | -280.54% | - |
| 2020 | 0.00% | - |